These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 20432857

  • 1. [Methoxy polyethylene glycol epoetin beta].
    Taéron C.
    Rev Infirm; 2010 Apr; (159):47-9. PubMed ID: 20432857
    [No Abstract] [Full Text] [Related]

  • 2. [Methoxy polyethylene glycol-epoetin beta (Mircera) in the treatment of a patient with chronic kidney disease presenting late-onset hypersensitivity to other epoetins].
    Dávila Fajardo CL, Peña Ortega M, Cabeza Barrera J, Prados Garrido MD.
    Nefrologia; 2010 Apr; 30(3):372-3. PubMed ID: 20514110
    [No Abstract] [Full Text] [Related]

  • 3. [Erythropoietin beta].
    Taéron C.
    Rev Infirm; 2006 Apr; (122):41-2. PubMed ID: 16881460
    [No Abstract] [Full Text] [Related]

  • 4. Methoxy polyethylene glycol-epoetin beta: new drug. Pegylated epoetin beta: risk of cardiovascular disorders.
    Prescrire Int; 2008 Oct; 17(97):191. PubMed ID: 19534043
    [Abstract] [Full Text] [Related]

  • 5. Darbepoetin alfa.
    Vance R.
    Clin J Oncol Nurs; 2003 Oct; 7(5):599-600. PubMed ID: 14603561
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Methoxy polyethylene glycol-epoetin beta: worth waiting for or a novelty worn off?
    Schmidt RJ.
    Expert Opin Pharmacother; 2009 Jun; 10(9):1509-14. PubMed ID: 19505218
    [Abstract] [Full Text] [Related]

  • 8. CERA: third-generation erythropoiesis-stimulating agent.
    Topf JM.
    Expert Opin Pharmacother; 2008 Apr; 9(5):839-49. PubMed ID: 18345959
    [Abstract] [Full Text] [Related]

  • 9. Methoxy polyethylene glycol-epoetin beta (CERA) induced restless legs syndrome.
    Inal S, Gölbaş C, Oneç K, Okyay GU, Derici UB.
    Ther Apher Dial; 2012 Aug; 16(4):378-9. PubMed ID: 22817128
    [No Abstract] [Full Text] [Related]

  • 10. Route of administration for erythropoiesis-stimulating agents: patient and nursing considerations.
    Holloway M.
    Nephrol Nurs J; 2007 Aug; 34(5):527-31. PubMed ID: 18041455
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of intravenous methoxy polyethylene glycol-epoetin beta administered every 2 weeks compared with epoetin administered 3 times weekly in patients treated by hemodialysis or peritoneal dialysis: a randomized trial.
    Klinger M, Arias M, Vargemezis V, Besarab A, Sulowicz W, Gerntholtz T, Ciechanowski K, Dougherty FC, Beyer U.
    Am J Kidney Dis; 2007 Dec; 50(6):989-1000. PubMed ID: 18037099
    [Abstract] [Full Text] [Related]

  • 12. Erythropoietin for anemia.
    Med Lett Drugs Ther; 1989 Sep 22; 31(801):85-6. PubMed ID: 2671624
    [No Abstract] [Full Text] [Related]

  • 13. Anemia management protocols: providing consistent hemoglobin outcomes.
    Michael M.
    Nephrol Nurs J; 2005 Sep 22; 32(4):423-6. PubMed ID: 16180783
    [Abstract] [Full Text] [Related]

  • 14. Toward confirmation of the safety and efficacy of methoxy polyethylene glycol-epoetin beta in anemia treatment in patients on hemodialysis: a Macedonian experience.
    Kacarska-Fotevska I, Volckova N, Ilievska K, Donev D.
    Croat Med J; 2019 Oct 31; 60(5):475-478. PubMed ID: 31686463
    [No Abstract] [Full Text] [Related]

  • 15. Management of anemia in chronic kidney disease (predialysis) patients: nephrology nursing implications.
    Wish JB, Weigel KA.
    Nephrol Nurs J; 2001 Jun 31; 28(3):341-5. PubMed ID: 12143456
    [Abstract] [Full Text] [Related]

  • 16. Methoxy polyethylene glycol-epoetin beta for the treatment of anemia associated with chronic renal failure.
    Schmid H.
    Expert Rev Hematol; 2016 Jan 31; 9(1):5-20. PubMed ID: 26573694
    [Abstract] [Full Text] [Related]

  • 17. Once-monthly subcutaneous C.E.R.A. maintains stable hemoglobin control in patients with chronic kidney disease on dialysis and converted directly from epoetin one to three times weekly.
    Sulowicz W, Locatelli F, Ryckelynck JP, Balla J, Csiky B, Harris K, Ehrhard P, Beyer U, PROTOS Study Investigators.
    Clin J Am Soc Nephrol; 2007 Jul 31; 2(4):637-46. PubMed ID: 17699476
    [Abstract] [Full Text] [Related]

  • 18. Once-weekly epoetin-beta in renal anemia: the clinical evidence.
    Albertazzi A.
    Contrib Nephrol; 2002 Jul 31; (137):408-11. PubMed ID: 12101986
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Clinical administration of epoetin alfa recombinant.
    Taylor BA, Weinstein SM.
    J Intraven Nurs; 1992 Jul 31; 15(2):78-82. PubMed ID: 1564606
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.